{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:43:20Z","timestamp":1793465000440,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Mesenchymal stem cells (MSCs) have been increasingly used for treating autoimmune diseases due to their immune modulation functions, but inefficient homing to the target tissue and safety issues limits their wide application. Recently, increasing studies demonstrate small extracellular vesicles (sEVs) as key mediators of MSCs to exert their immunomodulatory effects. In this study, we found that sEVs derived from human umbilical cord MSCs stimulated by IFN-\u03b3 (IFN\u03b3-sEVs) inhibited proliferation and activation of peripheral blood mononuclear cells and T cells <jats:italic>in vitro<\/jats:italic>. Furthermore, we confirmed that IFN\u03b3-sEVs reduced psoriasis symptoms including thickness, erythema, and scales of skin lesions; exhausted Th17 cells, increased Th2 cells; and reduced enrichment of inflammatory cytokines such as IL-17A, IFN-\u03b3, IL-6, and TNF-\u03b1 in both spleen and skin lesions <jats:italic>in vivo<\/jats:italic>. Importantly, IFN\u03b3-sEVs significantly improved the delivery efficiency and stability of ASO-210, the antisense oligonucleotides of miR-210 block the immune imbalance and subsequent psoriasis development. Our results reveal MSC-sEVs as promising cell-free therapeutic agents and ideal delivery vehicles of antisense oligonucleotides for psoriasis treatment.<\/jats:p>","DOI":"10.3389\/fcell.2022.842813","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:30:15Z","timestamp":1646915415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Small Extracellular Vesicles Derived From MSCs Have Immunomodulatory Effects to Enhance Delivery of ASO-210 for Psoriasis Treatment"],"prefix":"10.3389","volume":"10","author":[{"given":"Weixian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","first-page":"S2","article-title":"Pathogenesis and Treatment of Psoriasis: Exploiting Pathophysiological Pathways for Precision Medicine","volume":"33","author":"Alwan","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target Recognition and Regulatory Functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/nm.3016","article-title":"Hiding under the Skin: Interleukin-17-Producing \u03b3\u03b4 T Cells Go under the Skin?","volume":"18","author":"Becher","year":"2012","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5070\/d30w66c5gg","article-title":"A Systematic Review of Adverse Effects Associated with Topical Treatments for Psoriasis","volume":"9","author":"Bruner","year":"2003","journal-title":"Dermatol. Online J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.biocel.2008.01.007","article-title":"Mesenchymal Stem Cells: a Promising Candidate in Regenerative Medicine","volume":"40","author":"Chen","year":"2008","journal-title":"Int. J. Biochem. Cel Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative Responses to IL-17 and TNF-\u03b1 in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jdv.15920","article-title":"Systematic Review on Rapidity of Onset of Action for Interleukin\u201017 and Interleukin\u201023 Inhibitors for Psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1759720X19886505","DOI":"10.1177\/1759720X19886505","article-title":"The Role of Epigenetics and Immunological Imbalance in the Etiopathogenesis of Psoriasis and Psoriatic Arthritis","volume":"11","author":"Frischknecht","year":"2019","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040433","article-title":"The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery","volume":"9","author":"Gagliardi","year":"2021","journal-title":"Biomedicines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell stem cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaad.2018.03.040","article-title":"Safety and Efficacy of a Fixed Combination of Halobetasol and Tazarotene in the Treatment of Moderate-To-Severe Plaque Psoriasis: Results of 2 Phase 3 Randomized Controlled Trials","volume":"79","author":"Gold","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"eabi8823","DOI":"10.1126\/sciimmunol.abi8823","article-title":"TWEAK Functions with TNF and IL-17 on Keratinocytes and Is a Potential Target for Psoriasis Therapy","volume":"6","author":"Gupta","year":"2021","journal-title":"Sci. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1016\/j.celrep.2018.12.012","article-title":"Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation","volume":"25","author":"Hartwig","year":"2018","journal-title":"Cel Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1089\/hum.2015.072","article-title":"Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles","volume":"26","author":"Heldring","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8429042","article-title":"Comparison of Immunological Characteristics of Mesenchymal Stem Cells from the Periodontal Ligament, Umbilical Cord, and Adipose Tissue","volume":"2018","author":"Jin-Hee","year":"2018","journal-title":"Stem Cell Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis","volume":"130","author":"Kagami","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2019.11.009","article-title":"Systemic Delivery of microRNA-21 Antisense Oligonucleotides to the Brain Using T7-Peptide Decorated Exosomes","volume":"317","author":"Kim","year":"2020","journal-title":"J. Controlled Release"},{"key":"B19","first-page":"1468","article-title":"Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients with Psoriasis Vulgaris-Aa Randomized Phase III Study (PSO-FAST)","volume":"14","author":"Leonardi","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1002\/jcp.27669","article-title":"Interaction between Mesenchymal Stromal Cell\u2010derived Extracellular Vesicles and Immune Cells by Distinct Protein Content","volume":"234","author":"Mardpour","year":"2019","journal-title":"J. Cel Physiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"CD005028","DOI":"10.1002\/14651858.CD005028.pub2","article-title":"Topical Treatments for Chronic Plaque Psoriasis","volume":"2009","author":"Mason","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"B23","volume-title":"Mechanisms of Disease: Psoriasis","author":"Nestle","year":"2009"},{"key":"B24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the Cytokine Code in Psoriasis","volume":"13","author":"Nickoloff","year":"2007","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010042","article-title":"Mesenchymal Stem Cell-Derived Exosomes: Biological Function and Their Therapeutic Potential in Radiation Damage","volume":"10","author":"Pu","year":"2020","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","article-title":"Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders","volume":"13","author":"Riazifar","year":"2019","journal-title":"ACS nano"},{"key":"B27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal Stem Cells: Mechanisms of Inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacological Sciences"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e2102634","DOI":"10.1002\/advs.202102634","article-title":"Engineered Small Extracellular Vesicles as a FGL1\/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection","volume":"9","author":"Tsai","year":"2021","journal-title":"Adv. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1609206","DOI":"10.1080\/20013078.2019.1609206","article-title":"Defining Mesenchymal Stromal Cell (MSC)-derived Small Extracellular Vesicles for Therapeutic Applications","volume":"8","author":"Witwer","year":"2019","journal-title":"J. extracellular vesicles"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1172\/jci97426","article-title":"MicroRNA-210 Overexpression Promotes Psoriasis-like Inflammation by Inducing Th1 and Th17 Cell Differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"105218","DOI":"10.1016\/j.nbd.2020.105218","article-title":"Exosome-mediated Delivery of Antisense Oligonucleotides Targeting \u03b1-synuclein Ameliorates the Pathology in a Mouse Model of Parkinson's Disease","volume":"148","author":"Yang","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e12030","DOI":"10.1002\/jev2.12030","article-title":"Extracellular Vesicles: Natural Liver-Accumulating Drug Delivery Vehicles for the Treatment of Liver Diseases","volume":"10","author":"Zhang","year":"2020","journal-title":"J. Extracell Vesicles"},{"key":"B34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12935-020-01193-z","article-title":"Mesenchymal Stem Cells: a Promising Way in Therapies of Graft-Versus-Host Disease","volume":"20","author":"Zhou","year":"2020","journal-title":"Cancer Cel Int"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.842813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T12:30:24Z","timestamp":1646915424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.842813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":34,"alternative-id":["10.3389\/fcell.2022.842813"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.842813","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"842813"}}